Prolonged IL-10 Exposure Modulates Adaptive and Innate Immune Responses in Secondary Lymphoid Organs during Experimental Autoimmune Encephalomyelitis 2332777
The Journal of Immunology · 01.08.2026 · 215 (Supplement_1)
DOI: 10.1093/jimmun/vkag141.1821 ↗Kurz gefasst
Fachartikel in der Zeitschrift The Journal of Immunology, online erschienen am 28.07.2026. Verfasst von Erica Budina und 12 weiteren Autor:innen.
Abstract (Originalsprache)
Introduction
Interleukin-10 (IL-10) is a potent immunoregulatory cytokine that suppresses pro-inflammatory cytokine production, reduces antigen presentation by myeloid cells, promotes M2 macrophage polarization, and inhibits T cell activation. However, the clinical application of recombinant IL-10 is limited by its short plasma half-life and insufficient exposure in the secondary lymphoid organs (SLOs), key sites of autoreactive T cell priming in autoimmunity.
Methods
To address these limitations, we previously engineered a serum albumin-IL-10 fusion protein (SA-IL-10) with extended half-life and enhanced exposure in the SLOs. Here, using experimental autoimmune encephalomyelitis (EAE), a murine model of neuroinflammation, we subcutaneously administered SA-IL-10 and performed immunophenotyping in the SLOs and spinal cord to examine how sustained IL-10 exposure modulates immune responses under neuroinflammatory conditions.
Results
Immunophenotyping of the SLOs revealed that SA-IL-10 treatment reduced pathogenic, antigen-specific RORγt+ TH17 T cells, CD86+ M1-like macrophages, CD86+ dendritic cells and pro-inflammatory cytokine production, while expanding immunoregulatory CD206+ M2-like macrophages. Sustained IL-10 exposure expanded a novel checkpoint-high immunoregulatory TH2 phenotype, with GATA3+ TH2 cells expressing multiple immune checkpoint receptors, including CTLA-4, PD-1, TIGIT, and ICOS. Despite the absence of direct central nervous system targeting, SA-IL-10 treatment also reduced the infiltration of macrophages, dendritic cells, and CD4+ T cells in the spinal cord.
Conclusion
Together, these findings demonstrate that increasing IL-10 exposure in the SLOs alters peripheral immune priming and is associated with reduced pro-inflammatory immune cell infiltration in the spinal cord during EAE. Funding Source Alper Family Fund Grant (Awarded to Prof. Jeffrey A. Hubbell) Topic Categories Therapeutic Approaches to Autoimmunity (THER)
Zitieren
APA
Budina, E., Refvik, K., Reda, J., Luehr, J., Berg, B., Chun, H., Beckman, T., Solanki, A., Nguyen, M., Hultgren, K., Ishihara, J., Volpatti, L., & Hubbell, J. (2026). Prolonged IL-10 Exposure Modulates Adaptive and Innate Immune Responses in Secondary Lymphoid Organs during Experimental Autoimmune Encephalomyelitis 2332777. The Journal of Immunology, 215(Supplement_1). https://doi.org/10.1093/jimmun/vkag141.1821
Vancouver
Budina E, Refvik K, Reda J, Luehr J, Berg B, Chun H, et al. Prolonged IL-10 Exposure Modulates Adaptive and Innate Immune Responses in Secondary Lymphoid Organs during Experimental Autoimmune Encephalomyelitis 2332777. The Journal of Immunology. 2026;215(Supplement_1). doi:10.1093/jimmun/vkag141.1821
BibTeX
@article{Budina2026,
author = {Budina, Erica and Refvik, Kirsten and Reda, Joseph and Luehr, Julia and Berg, Brendan and Chun, Hye-Rin and Beckman, Taryn and Solanki, Ani and Nguyen, Mindy and Hultgren, Kevin and Ishihara, Jun and Volpatti, Lisa and Hubbell, Jeffrey},
title = {Prolonged IL-10 Exposure Modulates Adaptive and Innate Immune Responses in Secondary Lymphoid Organs during Experimental Autoimmune Encephalomyelitis 2332777},
journal = {The Journal of Immunology},
year = {2026},
volume = {215},
number = {Supplement_1},
doi = {10.1093/jimmun/vkag141.1821}
}
EUVIMED